About
Patrick is Portal Instruments' Chief Executive Officer. Patrick brings more than 18 years of experience leading high-tech bioengineering companies from the lab to the market place and building world-class teams. Prior to founding Portal Instruments, from 2009 to 2012, he was co-founder and director of strategic planning for SynapDx Corporation, where he had responsibility for development of the company's business and operational plans as well as securing Series A funding. SynapDx went on to raise more than $40 million in venture capital to develop the first test to detect the early onset of autism using technologies licensed exclusively from Boston Children's Hospital and George Washington University. He also co-founded Aretais, Inc. to develop a non-invasive method to detect blood glucose using Coherent Anti-Stokes Raman Spectroscopy (CARS) backed by Pfizer, Inc. Patrick began his career as a science and nanotechnology equity research analyst at Susquehanna International Group, author
Position in the VCSift Database
- • 371 investors hold the CEO and Co-Founder role in VCSift. Patrick Anquetil is one of them.
- • 25 investors are based in Brookline, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Brookline, US
Contact Information
Find more investors like Patrick
Search Investors